REFR — Research Frontiers Balance Sheet
0.000.00%
- $63.60m
- $62.46m
- $1.34m
Annual balance sheet for Research Frontiers, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4.77 | 3.03 | 4.23 | 2.48 | 1.99 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.598 | 0.832 | 0.59 | 1 | 0.658 |
| Prepaid Expenses | |||||
| Total Current Assets | 5.43 | 3.95 | 4.92 | 3.58 | 2.75 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.738 | 0.563 | 0.389 | 0.218 | 1.24 |
| Other Long Term Assets | |||||
| Total Assets | 6.2 | 4.55 | 5.37 | 3.85 | 4.04 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 0.226 | 0.298 | 0.302 | 0.277 | 0.269 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.872 | 0.762 | 0.57 | 0.333 | 1.44 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 5.33 | 3.78 | 4.8 | 3.52 | 2.6 |
| Total Liabilities & Shareholders' Equity | 6.2 | 4.55 | 5.37 | 3.85 | 4.04 |
| Total Common Shares Outstanding |